Pharmacokinetics of polymyxin B in different populations: a systematic review
ConclusionWe conclude that small sample sizes, lack of multicentre collaboration, and patient homogeneity are the primary reasons for the discrepancies in the results of the current studies. In addition, most of the studies limited in the internal evaluation, which confined the implementation of model-informed precis ion dosing strategies.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cystic Fibrosis | Databases & Libraries | Drugs & Pharmacology | Eating Disorders & Weight Management | Kidney Transplant | Kidney Transplantation | Lung Transplant | Multidrug Resistance | Obesity | Pediatrics | Polymyxin B | Study | Transplant Surgery | Transplants | Urology & Nephrology